Agenus will consider IST’s utilizing botensilimab +/- balstilimab or other agents external to our pipeline. Other agents in our pipeline are not currently open to IST proposals except on a case-by-case basis. Particular consideration will be given to IST’s designed to:
Additional consideration will be given to studies that have:
If this is your first time applying for an IST, please register by clicking on the "Register" button to the right. Otherwise, login to the IST Portal using your email and password.
Please log in to the IST Portal by entering your email and password in the fields below: